본문바로가기
Q
U
I
C
K

SK bioscience

SK bioscience is growing into a domestic and global vaccine developer by
continuously making investments and establishing infrastructure for vaccine development.

Company Overview

SK bioscience is a vaccine company that was spun off from SK Chemicals in 2018.

In 2008, SK bioscience selected premium vaccines as the next-generation growth engine and has made continuous investments in production and infrastructure ever since.
As a result of these efforts, significant accomplishments have been made, starting with the launch of the cell-cultured trivalent flu vaccine in 2015, followed by the cell-cultured quadrivalent flu vaccine, the zoster vaccine, and the varicella vaccine. Based on our excellent vaccine research capabilities, we are also jointly developing the next-generation pneumococcal vaccine with global vaccine producer Sanofi Pasteur. From 2020, SK bioscience is preparing a full-fledged entry into the global market with not just the development of the COVID-19 vaccine, but CMO and CDMO contracts with leading overseas vaccine developers too.

SK bioscience logo
Vaccine Development 2001~
  • Acquired Dongshin Pharm (2001)
  • Established Vaccine R&D Center (2005)
  • Established Pan-gyo HQ
  • Construction of L HOUSE
    (Andong Vaccine Plant)
  • Established SK bioscience (2018)

Subsidiaries of SK Group

  • Subsidiaries of SK Group strive to achieve growth and development via the “separately and together” strategy. Each subsidiary not only promotes enhancement of business competitiveness and maximization of enterprise value through autonomous and responsible management, but also spontaneously collaborates with other subsidiaries to create greater value.

  • SK Discovery has highly competitive businesses in eco-friendly materials, vaccines, pharmaceuticals, energy/chemicals, and real estate development. All our employees are committed to enhancing the business competitiveness of our subsidiaries and increasing shareholder value by establishing a foundation for continuous growth through efficient management and financial stability.

  • Originally established as Sunkyong Fibers Ltd. in 1969, SK CHEMICALS has been leading the innovation and change in chemicals and life science in Korea. SK Chemicals set itself the mission to “promote human health and protect the environment” and reorganized the business structure to focus on two pillars: “Green Chemicals” and “Life Science.” With the goal “to become a global leader in eco-friendly materials and total healthcare solutions,” the pharmaceutical giant provides chemicals and life science products and solutions that are necessary for humanity.